Tevimbra approved for HER2-negative gastric or gastroesophageal junction adenocarcinoma with PD-L1 expression, in combination ...
An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...
A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on ...